Valuation Cutia Therapeutics

Stocks

Delayed Hong Kong S.E. 04:08:20 2026-10-20 EDT			5-day change	1st Jan Change
0.7500 ^HKD	-12.79%		+2.04%	-83.48%

10-19	Fangzhou Inc. and Cutia Therapeutics Partners to Advance Ai-Powered Dermatology and Chronic Health Management	CI
10-05	Cutia Therapeutics commences an Equity Buyback Plan for 36,336,827 shares, representing 10% of its issued share capital, under the authorization approved on June 26, 2026.	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2023	2024	2025	2026	2027	2028
Market Cap ¹	3,030	2,120	1,482	238.2	-	-
Change	-	-30.05%	-30.06%	-83.93%	-	-
Enterprise Value (EV)	2,471	2,055	1,469	238.2	238.2	238.2
Change	-	-16.83%	-28.53%	-83.78%	0%	0%
P/E	-1.04x	-4.72x	-3.96x	21.3x	4.56x	-
PBR	2.25x	2.17x	1.52x	0.36x	0.34x	-
PEG	-0x	0.1x	0.1x	-0x	0x	-
Capitalization / Revenue	22x	7.58x	4.41x	0.41x	0.25x	0.18x
EV / Revenue	0x	0x	0x	0.41x	0.25x	0.18x
EV / EBITDA	-0x	-0x	-0x	9.16x	3.31x	-
EV / EBIT	-0x	-0x	-0x	23.8x	4.33x	2.46x
EV / FCF	-0x	-0x	-0x	-8.21x	-7.44x	-5.67x
FCF Yield	-14.4%	-22.1%	-20.4%	-12.2%	-13.4%	-17.6%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	-9.6	-1.41	-1.03	0.03	0.14	-
Distribution rate	-	-	-	-	-	-
Net sales ¹	137.6	279.6	336.2	588	961	1,336
EBITDA ¹	-498	-419.9	-257.9	26	72	-
EBIT ¹	-538.9	-461.1	-300.1	10	55	97
Net income ¹	-1,964	-433.8	-340.2	10	50	-
Net Debt	-559.6	-64.73	-13.8	-	-	-
Reference price ²	9.9667	6.6531	4.0798	0.6383	0.6383	0.6383
Nbr of stocks (in thousands)	304,024	318,588	363,368	373,171	-	-
Announcement Date	3/27/24	3/24/25	3/24/26	-	-	-

¹CNY in Million²CNY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
CUTIA THERAPEUTICS	24.43x	-	-	-	40.89M
ELI LILLY AND COMPANY	35.75x	12.79x	26.94x	0.55%	1,106B
JOHNSON & JOHNSON	37.14x	6.26x	17.62x	2.1%	612B
ABBVIE INC.	36.08x	8.31x	17.14x	2.43%	500B
ROCHE HOLDING AG	20.6x	4.98x	12.38x	2.63%	367B
MERCK & CO., INC.	104.7x	5.86x	25.15x	2.37%	354B
NOVARTIS AG	21.05x	5.51x	13.55x	2.9%	286B
ASTRAZENECA PLC	21.56x	4.37x	12.5x	2.02%	256B
AMGEN INC.	26.98x	6.96x	12.46x	2.37%	230B
GILEAD SCIENCES, INC.	-44.72x	6.87x	26.59x	2.15%	190B
Average	28.36x	6.88x	18.26x	2.17%	390.02B
Weighted average by Cap.	34.40x	8.11x	19.89x	1.85%